Sumco Corp
TSE:3436
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Sumco Corp
Cash & Cash Equivalents
Sumco Corp
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sumco Corp
TSE:3436
|
Cash & Cash Equivalents
ÂĄ190B
|
CAGR 3-Years
29%
|
CAGR 5-Years
30%
|
CAGR 10-Years
21%
|
|
Tokyo Electron Ltd
TSE:8035
|
Cash & Cash Equivalents
ÂĄ462.4B
|
CAGR 3-Years
35%
|
CAGR 5-Years
21%
|
CAGR 10-Years
23%
|
|
Lasertec Corp
TSE:6920
|
Cash & Cash Equivalents
ÂĄ29.7B
|
CAGR 3-Years
17%
|
CAGR 5-Years
16%
|
CAGR 10-Years
20%
|
|
Disco Corp
TSE:6146
|
Cash & Cash Equivalents
ÂĄ215.5B
|
CAGR 3-Years
25%
|
CAGR 5-Years
19%
|
CAGR 10-Years
21%
|
|
Ulvac Inc
TSE:6728
|
Cash & Cash Equivalents
ÂĄ95.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
|
Screen Holdings Co Ltd
TSE:7735
|
Cash & Cash Equivalents
ÂĄ167.3B
|
CAGR 3-Years
39%
|
CAGR 5-Years
39%
|
CAGR 10-Years
17%
|
See Also
What is Sumco Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
190B
JPY
Based on the financial report for Mar 31, 2024, Sumco Corp's Cash & Cash Equivalents amounts to 190B JPY.
What is Sumco Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
21%
Over the last year, the Cash & Cash Equivalents growth was -7%. The average annual Cash & Cash Equivalents growth rates for Sumco Corp have been 29% over the past three years , 30% over the past five years , and 21% over the past ten years .